Global Personalized Nutrition Market Size, Share, Trends, & Growth Forecast Report Segmented By Product Type (Active Measurement, Standard Measurement, Functional Foods & Beverages, Dietary Supplements & Nutraceuticals, Sports Nutrigenomics, Digitized DNA-Based Diet Routines), Application, End user, Form, And Region (North America, Europe, APAC, Latin America, Middle East And Africa) – Industry Analysis From 2026 To 2034
The global personalized nutrition market size was worth USD 12.47 billion in 2025 and is predicted to be worth USD 14.34 billion in 2026 to USD 43.87 billion by 2034, growing at a CAGR of 15.0% during the forecast period.

The Personalized Nutrition refers to a data-driven approach to dietary planning that tailors food and supplement recommendations to an individual’s genetic profile, metabolic response, microbiome composition, lifestyle, and health objectives. Unlike generalized dietary guidelines, personalized nutrition leverages advanced diagnostics and digital health platforms to deliver precise, actionable insights aimed at preventing chronic disease, optimizing wellness, and improving metabolic outcomes. A survey in early 2022 found that about 41% of U.S. consumers owned a smartwatch or fitness tracker, up from the previous year. According to the CDC, six out of every ten adults in the United States have at least one chronic disease. The most common chronic conditions include heart disease, cancer, diabetes, and stroke. Furthermore, the Human Microbiome Project has identified over 10,000 microbial species in the human gut, with composition varying significantly between individuals is escalating the biological rationale for customized dietary strategies.
The rising prevalence of diet-related chronic diseases and the shift toward preventive healthcare is significantly driving the growth of Personalized Nutrition Market. According to the Centers for Disease Control and Prevention, more than 11% of the U.S. population has diagnosed diabetes, and an additional 38% suffer from prediabetes, which conditions heavily influenced by dietary patterns. This has prompted healthcare providers and insurers to explore personalized nutrition as a cost-effective intervention. As per the American Diabetes Association, the structured lifestyle programs, including individualized meal planning, can reduce the risk of type 2 diabetes onset by up to 58% in high-risk individuals. As per the U.S. Preventive Services Task Force, behavioral counseling for adults with cardiovascular risk factors is creating a policy foundation for nutrition personalization. Employers are also adopting personalized wellness programs; for instance, the Integrated Benefits Institute reports that companies offering tailored health interventions saw a reduction in absenteeism and a drop in medical claims over three years.
The integration of artificial intelligence and wearable biosensors into consumer health platforms by enabling real-time metabolic feedback and dynamic dietary adjustments is majorly boosting the growth of Personalized Nutrition Market. Devices such as continuous glucose monitors (CGMs), once limited to diabetic patients, are now used by metabolically healthy individuals seeking optimization. According to the Food and Drug Administration, did recently approve the first over-the-counter (OTC) CGM in March 2025, which is intended for non-insulin users for general wellness purposes. Companies like Levels and Nutrisense leverage this data to provide users with personalized food response scores. As per the MIT Media Lab demonstrated that individuals consuming identical meals exhibited highly variable glucose responses, with differences of up to 70 mg/dL between participants is validating the need for individualized guidance.
The lack of standardized regulatory oversight for nutrigenomic testing and algorithmic recommendations is majorly restraining the growth of Personalized Nutrition Market. As per the U.S. Food and Drug Administration regulates some genetic tests as medical devices, but many direct-to-consumer nutrition platforms operate in a gray area is offering insights without clinical validation. According to the Government Accountability Office, most of the commercially available nutrigenomic tests in 2022 provided inconsistent or non-actionable results when cross-validated with peer-reviewed studies. According to the Federal Trade Commission has issued warnings to several companies for making unsubstantiated health claims based on genetic data. According to the American Society of Human Genetics cautions that most gene-diet interactions lack sufficient evidence for clinical application. This regulatory ambiguity hinders the consumer trust and limits insurance reimbursement is inhibiting widespread integration into mainstream healthcare despite technological advancements.
The socioeconomic disparity in access to personalized nutrition technologies. According to the U.S. Census Bureau, only few of households earning below $40,000 annually have used any form of digital health tool for dietary management, compared to 76% of those earning over $100,000. The cost of comprehensive testing, which is ranging from $200 to $500 for microbiome or genetic panels and subscription-based coaching services creates a barrier for low- and middle-income populations. According to the Kaiser Family Foundation report, that 43% of Americans cite cost as the primary reason for not adopting personalized wellness programs. Furthermore, the National Institute on Minority Health and Health Disparities indicates that racial and ethnic minorities are underrepresented in genomic databases is leading to less accurate recommendations for non-European populations. This inequity risks widening health gaps rather than closing them is challenging the scalability and ethical integrity of the market.
The integration of personalized nutrition into employer-sponsored wellness and health insurance programs is escalating the growth opportunities for Personalized Nutrition Market. An older RAND Employer Survey, cited in a National Institutes of Health article, that half of all U.S. employers offered wellness programs and that 72% of employers who offered a program characterized it as a mix of screening and interventions. As per the report by the Health Enhancement Research Organization, UnitedHealthcare and Aetna have piloted programs that subsidize personalized nutrition plans for members with metabolic syndrome, which is resulting in a 33% improvement in HbA1c levels and a 22% reduction in pharmacy costs over 12 months. According to the Centers for Medicare & Medicaid Services is exploring value-based reimbursement models that incentivize dietary interventions for chronic disease management. As per the U.S. Department of Labor found that every dollar invested in evidence-based wellness programs yields $3.27 in reduced healthcare costs and absenteeism is making personalized nutrition a financially viable strategy for payers and employers alike.
The advancement of AI-powered digital nutritionists and conversational health assistants is creating opportunities for the growth of Personalized Nutrition Market. These virtual coaches use natural language processing and machine learning to deliver real-time, adaptive dietary guidance. According to the Pew Research Center, more than half of U.S. adults prefer digital tools over in-person consultations for routine health advice. According to the Veterans Health Administration conducted a 2023 trial using an AI nutrition chatbot for veterans with obesity, achieving a 15% average weight loss over six months is surpassing traditional counseling outcomes. As per the National Library of Medicine, it reports that AI-driven platforms improve user engagement by sending context-aware reminders is analyzing food logs via image recognition, and adjusting recommendations based on biometric feedback. With over millions of Americans owning smartphones, the scalability of AI nutritionists presents a cost-effective pathway to democratize access, particularly in underserved areas with limited dietitian availability.
The fragmentation of data sources and lack of interoperability between health platforms is posing significant challenges in the growth of Personalized Nutrition Market. Genetic data, gut microbiome reports, wearable biosensors, and electronic health records often reside in siloed systems with incompatible formats. According to the Office of the National Coordinator for Health Information Technology, a 2025 data brief reported that in 2023, 70% of hospitals were engaged in all four domains of interoperable exchange (send, receive, find, and integrate) at least sometimes. This hinders the creation of a unified health profile necessary for accurate personalization. As per the Healthcare Information and Management Systems Society (HIMSS) estimates that data integration delays add an average of 14 days to the delivery of personalized nutrition plans. Without standardized APIs and secure data-sharing protocols, even advanced algorithms cannot deliver holistic insights is limiting the clinical utility and scalability of personalized interventions across care settings.
The limited clinical validation and long-term efficacy data for many personalized nutrition programs is creating challenges in the expansion of Personalized Nutrition Market growth. While pilot studies show promise, large-scale, longitudinal trials are scarce. For Instance, NIH launched the "Nutrition for Precision Health" study, which aims to enroll 10,000 volunteers to personalize dietary guidance using advanced technologies and a multi-omics approach. This initiative focused the recognition of the need for larger, more comprehensive studies. As per the Cochrane Library reviewed 18 studies in 2023 and concluded that while short-term adherence improves, there is insufficient evidence to confirm sustained health benefits over time. According to the American Heart Association, which emphasizes that most commercial platforms lack peer-reviewed validation of their algorithms. This evidence gap makes healthcare providers hesitant to recommend services and insurers reluctant to cover them. Until robust clinical data is established, the market will remain constrained by skepticism from medical professionals and payers despite strong consumer interest.
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 15% |
| Segments Covered | By Product Type, Application, End User, Form, And Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC; PESTLE Analysis. Porter’s Five Forces Analysis, Competitive Landscape; Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, APAC, Latin America, Middle East & Africa |
| Market Leaders Profiled | Amway (US), BASF (Germany), DSM (Netherlands), Herbalife Nutrition Ltd (US), DNAfit (UK), Care/of (US), Nutrigenomix (US), Zipongo (US), Viome (US), Habit (US), and Atlas Biomed Group Limited (UK) |
The Dietary Supplements & Nutraceuticals segment dominated the Personalized Nutrition Market by capturing a 34% of share in 2025. The widespread consumer trust in supplement usage and the ease of customization through encapsulated formulations is driving the segment growth. According to the National Institutes of Health, more than half of U.S. adults regularly consume dietary supplements, with multivitamins, omega-3s, and vitamin D being the most prevalent. The segment benefits from direct integration with at-home testing kits such as those from InsideTracker and Thorne that analyze biomarkers and recommend tailored supplement regimens. As per the U.S. Food and Drug Administration, that over 80,000 dietary supplement products are commercially available, many now offering personalization via algorithmic dosing. According to the American Society for Nutrition, mentions that micronutrient deficiencies affect most of Americans is reinforcing demand for targeted supplementation as a preventive health strategy.
The Digitized DNA-Based Diet Routines segment is predicted to expand at a CAGR of 16.8% from 2026 to 2034 in Personalized Nutrition Market. The surge is driven by increasing consumer access to affordable genetic testing and growing awareness of gene-diet interactions. Companies like 23andMe and DNAFit offer nutrition reports based on single nucleotide polymorphisms (SNPs) linked to lactose intolerance, caffeine metabolism, and fat processing. A study published in Nature Medicine demonstrated that individuals following DNA-based diets improved adherence and achieved better weight outcomes than those on standard plans. Furthermore, the integration of AI to interpret polygenic risk scores for metabolic conditions is enhancing the scientific credibility and scalability of these digital platforms.
Weight Management led the Personalized Nutrition Market by accounting for 28.9% of share in 2025. The growth is fueled by the escalating prevalence of overweight and obesity, with the Centers for Disease Control and Prevention reporting that 41.9% of U.S. adults are obese a condition directly influenced by dietary habits. Personalized approaches offer a departure from one-size-fits-all diets by incorporating metabolic rate, insulin sensitivity, and behavioral patterns into weight loss strategies. As per the American Heart Association, that personalized interventions result in 2.3 times greater weight loss sustainability over 12 months compared to generic programs. Platforms like Noom and Zoe leverage psychological profiling and microbiome analysis to tailor calorie intake and food sequencing by improving long-term adherence. The employer wellness programs increasingly subsidize personalized weight management, with the Integrated Benefits Institute confirming a 29% reduction in healthcare costs for participating employees.
The Metabolic Health segment is estimated to grow at a CAGR of 15.4% from 2026 to 2034 in Personalized Nutrition Market. This rapid expansion is driven by rising insulin resistance and prediabetes rates, affecting over 96 million American adults. Personalized nutrition is increasingly used to modulate blood glucose, lipid profiles, and inflammation through real-time feedback from continuous glucose monitors (CGMs). As per the Joslin Diabetes Center report, that 68% of prediabetic patients who followed individualized meal plans reversed metabolic dysfunction within nine months. Companies like Levels and Nutrisense combine CGM data with AI to identify food-specific glycemic responses by enabling users to avoid metabolic spikes. According to the U.S. Preventive Services Task Force now recommends intensive behavioral interventions for adults with elevated HbA1c is creating a clinical mandate for personalized dietary solutions. As metabolic syndrome becomes a primary focus of preventive medicine, this segment is poised for sustained acceleration.
The Direct-to-Consumer (DTC) segment dominated the Personalized Nutrition Market by representing 46.7% of share in 2025. The growing consumer autonomy over health decisions and the proliferation of digital health platforms that bypass traditional medical gatekeepers is majorly driving the segment growth. As per the Federal Trade Commission DTC health testing sales grew by 52% between 2020 and 2023, which is driven by convenience and privacy. As per the Journal of Medical Internet Research, DTC users exhibit higher engagement and adherence due to immediate feedback and gamified interfaces is reinforcing the model’s appeal in a self-directed wellness culture.
The Hospitals & Clinics segment is estimated to expand at a CAGR of 13.7% from 2026 to 2034 in Personalized Nutrition Market. This growth is fueled by the integration of precision nutrition into chronic disease management and preventive care protocols. The leading institutions such as the Mayo Clinic and Cleveland Clinic have launched personalized nutrition programs for patients with diabetes, cardiovascular disease, and gastrointestinal disorders. According to the National Academy of Medicine, emphasize that nutrition is the most underutilized clinical tool, with only 14% of medical schools meeting recommended nutrition education hours. To bridge this gap, hospitals are partnering with digital health firms to embed AI-powered nutrition platforms into electronic health records. According to Healthcare Effectiveness Data and Information Set (HEDIS), which includes dietary counseling metrics is incentivizing providers to adopt structured, data-driven interventions. As value-based care models prioritize outcomes over volume, hospitals are increasingly investing in scalable personalized nutrition solutions.
North America was the top performer in the global Personalized Nutrition Market by capturing 42.3% of share in 2025. The region’s growth is anchored in high healthcare spending, robust biotech innovation, and widespread adoption of digital health technologies is majorly driving the nation’s market growth. The Food and Drug Administration has approved several AI-driven nutrition platforms for use in clinical settings by enhancing credibility. As per the Centers for Disease Control and Prevention report, that diet-related chronic diseases cost the U.S. healthcare system $50 billion annually is driving investment in preventive solutions. With major tech firms, research institutions, and insurers actively collaborating on metabolic health initiatives, North America remains the epicenter of innovation and commercialization in personalized nutrition.
Europe occupies the second-largest share in Personalized Nutrition Market by capturing 29.6% in 2025. The market status in Europe is characterized by strong regulatory frameworks and public healthcare integration. According to the European Food Safety Authority has established strict guidelines for health claims on personalized nutrition products by ensuring scientific rigor. Countries like Germany, the UK, and the Netherlands lead in clinical adoption, with the National Health Service piloting microbiome-based dietary programs for IBS patients. As per the European Commission’s Horizon Europe program, which has allocated millions to projects linking genomics and nutrition is fostering cross-border research. The region’s emphasis on data privacy under GDPR also shapes consumer trust is influencing how companies design secure, transparent platforms for sensitive health information.
Asia Pacific Personalized Nutrition Market is distinguished by rapid urbanization and rising health consciousness. The region’s market status reflects growing middle-class affluence and increasing prevalence of metabolic disorders. In 2022, India was estimated to have 212 million people with diabetes, making it the country with the highest number of cases in the world. Japan leads in technological adoption, with over 3.2 million citizens using government-endorsed “Shokuiku” (food education) programs integrated with health data tracking. As per the Singapore Ministry of Health, launched a national initiative to incorporate AI-driven dietary advice into primary care. However, genetic data diversity and regulatory heterogeneity remain challenges to uniform scaling.
Latin America market is in the early stages of market development. The region’s market status is defined by increasing awareness of diet-related diseases and the emergence of localized digital health startups. Brazil leads in innovation, with companies like Nutrilyze offering AI-based meal planning integrated with local food databases. According to Brazilian Ministry of Health reports that obesity rates have doubled since 2006, affecting 22.4% of adults, which is prompting public and private sector interest in personalized interventions. As per the Economic Commission for Latin America and the Caribbean, that telehealth adoption surged by 80% post-pandemic is creating a pathway for digital nutrition services. However, limited access to genetic testing and low insurance coverage for preventive care constrain scalability. Despite these barriers, rising smartphone penetration and social media influence are driving consumer curiosity and early adoption in urban centers.
Middle East & Africa Market is enlarging with significant variation between sub-regions. According to the Gulf Cooperation Council (GCC) countries, particularly the UAE and Saudi Arabia, are driving growth through national health transformation agendas. For Instance, UAE’s Ministry of Health and Prevention has launched a personalized nutrition initiative under its National Strategy for Wellbeing 2031 is targeting diabetes and obesity. As per Saudi Arabia’s Vision 2030 includes investments in genomics and preventive healthcare, with the King Abdullah International Medical Research Center conducting studies on gene-diet interactions in Arab populations. In contrast, Sub-Saharan Africa faces infrastructural and economic barriers, though mobile health platforms are gaining traction. The African Union’s Africa Centres for Disease Control projects that diet-related non-communicable diseases are rising faster here than in any other region is signaling future demand for scalable, culturally adapted personalized nutrition solutions.
Nestlé Health Science has positioned itself as a global leader in personalized nutrition by integrating clinical research with scalable consumer solutions. In the Asia Pacific region, the company has launched region-specific initiatives such as "Nestlé Personalized Nutrition" in Japan and Singapore, which is leveraging local dietary preferences and metabolic data to tailor medical and wellness nutrition products. In 2023, it partnered with the Singapore Health Promotion Board to pilot AI-driven dietary recommendations for prediabetic individuals by integrating glycemic response algorithms developed from regional clinical trials. The company also introduced culturally adapted probiotic formulations in India and Thailand based on gut microbiome studies conducted in collaboration with local universities. By combining genomics, metabolomics, and digital health platforms like its proprietary "MyYou" app, Nestlé Health Science is advancing science-backed personalization while aligning with public health goals across diverse Asian populations.
Danone Nutricia Research is at the forefront of microbiome-based personalized nutrition, with significant investments in Asia Pacific to understand regional gut health dynamics. The company established a dedicated research center in Shanghai focused on mapping the gut microbiota of East Asian populations is revealing distinct microbial profiles compared to Western cohorts. In 2022, Danone launched a personalized yogurt initiative in South Korea using microbiome data to customize prebiotic and probiotic blends for individual consumers. It also collaborated with Japan’s RIKEN Institute to study the impact of traditional fermented foods on metabolic health is informing product development. Through its partnership with Singapore’s Agency for Science, Technology and Research, Danone is developing AI models to predict dietary responses in Southeast Asian populations. These efforts mark its strategy of combining local scientific insights with global innovation to deliver culturally relevant, evidence-based personalized nutrition solutions.
Zoe, a science-led personalized nutrition company, has expanded its influence in the Asia Pacific market by leveraging its landmark PREDICT studies on individual metabolic responses to food. The company is headquartered in the U.S. and U.K. Zoe has intensified collaborations with research institutions in Australia and New Zealand to validate its algorithmic models on non-European populations. In 2023, it partnered with the University of Sydney to conduct metabolic trials on Australian adults is incorporating local dietary patterns into its digital platform. The company introduced localized food databases for Southeast Asian cuisines is enabling accurate glycemic and inflammatory response predictions for users in Malaysia and Indonesia. Zoe’s mobile app, which provides real-time food scoring based on blood markers and gut microbiome analysis, has gained traction among health-conscious urban consumers. By emphasizing peer-reviewed science and transparent data interpretation, Zoe is building credibility in a region increasingly skeptical of unverified health claims by positioning itself as a trusted provider of precision nutrition.
Key players in the Personalized Nutrition Market are deploying integrated strategies centered on scientific validation, digital health integration, and regional customization to enhance their competitive standing. Companies are investing heavily in clinical research to substantiate claims and gain regulatory credibility, particularly in regions with strict health claim regulations. Strategic partnerships with academic institutions, hospitals, and government health bodies are enabling access to diverse population data and enhancing trust. Firms are also leveraging artificial intelligence and machine learning to interpret complex datasets from genomics, metabolomics, and microbiome analyses, delivering dynamic, real-time dietary recommendations. Expansion into Asia Pacific and other emerging markets is being driven by localization of algorithms, culturally adapted product formulations, and mobile-first platforms. The direct-to-consumer engagement through subscription models and digital coaching is becoming a dominant channel for sustained user retention and data accumulation.
Major Key Players in the global personalized nutrition market are Amway (US), BASF (Germany), DSM (Netherlands), Herbalife Nutrition Ltd (US), DNAfit (UK), Care/of (US), Nutrigenomix (US), Zipongo (US), Viome (US), Habit (US), and Atlas Biomed Group Limited (UK)
The competition in the Personalized Nutrition Market is intensifying as traditional food and supplement companies converge with digital health startups and biotech innovators. Market growth is no longer determined by brand recognition alone but by scientific rigor, data depth, and technological sophistication. Incumbents are differentiating through clinical validation and regulatory compliance, while disruptors emphasize user experience, real-time feedback, and AI-driven personalization. The integration of continuous biosensors, genetic testing, and microbiome analysis has raised the barrier to entry by favoring players with multidisciplinary expertise. Regional adaptation is becoming crucial, as metabolic responses vary significantly across ethnic and dietary groups. Intellectual property in algorithm development and biomarker interpretation is emerging as a key competitive asset. As consumers demand transparency and efficacy, the market is shifting from novelty to clinical credibility by reshaping competitive dynamics across geographies and applications.
By Product Type
By Application
By End User
By Form
By Region
Frequently Asked Questions
Genetic testing, artificial intelligence (AI), machine learning algorithms, and data analytics are crucial in analyzing individuals' unique traits and providing personalized dietary advice.
Genetic testing helps identify genetic variations related to metabolism, nutrient absorption, and food sensitivities. This information is used to create personalized diet plans better suited to an individual's genetic profile.
Personalized nutrition can improve health outcomes by addressing specific nutritional needs, optimizing nutrient intake, supporting weight management, managing chronic conditions, and reducing the risk of diet-related diseases.
Rising health awareness, growth of preventive healthcare, advancements in genomics, and increasing adoption of digital health technologies.
Personalized supplements, functional foods, meal plans, nutrition apps, DNA-based diet tests, and microbiome-based solutions.
Personalized dietary supplements dominate due to high consumer demand for targeted health benefits.
AI, mobile apps, wearable devices, and data analytics enable real-time dietary recommendations and tracking.
High costs, data privacy concerns, regulatory complexity, and limited awareness in developing regions.
Microbiome-based nutrition, AI-driven recommendations, subscription models, and plant-based personalized products.
The market is expected to grow rapidly, driven by technological innovation, personalized healthcare demand, and consumer focus on wellness.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region